Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MACH7 TECHNOLOGIES LIMITED Director's Dealing 2016

Jun 27, 2016

65285_rns_2016-06-27_7f4bf562-ceaf-4f7c-b06c-b5c871b1969a.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity Mach7 Technologies Limited ABN 26 007 817 192

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Dr. Nigel Finch
Date of last notice 12 April 2016

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest Direct and indirect interest
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances giving rise
to the relevant interest.
Finch Family Office Pty Ltd, a company which the
Director controls.
Date of change 28 June 2016
No. of securities held prior to
change

2,214,317 ordinary shares held jointly as Dr
Nigel Finch and Mrs Elizabeth Jane Finch

1,000,000 ordinary shares held by Finch
Family Office Pty Ltd A/C>

711,659 options exercisable at $0.05 each
on or before 6 August 2016 held jointly as Dr
Nigel Finch and Mrs Elizabeth Jane Finch

424,257 options exercisable at $0.05 each
on or before 6 February 2017 held jointly as
Dr Nigel Finch and Mrs Elizabeth Jane Finch

1,250,000 LTIP options exercisable at $0.10
each, vesting on 8 April 2018 and expiring on
8 April 2021, held by Finch Family Office Pty
Ltd
Class Ordinary shares
Number acquired 400,000 ordinary shares
  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Number disposed Nil
Value/Consideration
Note: If consideration is non-cash, provide details and
estimated valuation
$0.041 per share
No. of securities held after change
2,214,317 ordinary shares held jointly as Dr
Nigel Finch and Mrs Elizabeth Jane Finch

1,400,000 ordinary shares held by Finch
Family Office Pty Ltd A/C>

711,659 options exercisable at $0.05 each
on or before 6 August 2016 held jointly as Dr
Nigel Finch and Mrs Elizabeth Jane Finch

424,257 options exercisable at $0.05 each
on or before 6 February 2017 held jointly as
Dr Nigel Finch and Mrs Elizabeth Jane Finch

1,250,000 LTIP options exercisable at $0.10
each, vesting on 8 April 2018 and expiring on
8 April 2021, held by Finch Family Office Pty
Ltd
Nature of change
Example: on-market trade, off-market trade, exercise
of options, issue of securities under dividend
reinvestment plan, participation in buy-back
On-market trade

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract N/A
Nature of interest N/A
Name of registered holder
(if issued securities)
N/A
Date of change N/A
No. and class of securities to
which interest related prior to
change
Note: Details are only required for a contract in
relation to which the interest has changed
N/A
Interest acquired N/A
Interest disposed N/A
Value/Consideration
Note: If consideration is non-cash, provide details
and an estimated valuation
N/A
Interest after change N/A
  • See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Part 3 –[+] Closed period

Were the interests in the securities or contracts No detailed above traded during a[+] closed period where prior written clearance was required?

If so, was prior written clearance provided to allow the N/A trade to proceed during this period?

If prior written clearance was provided, on what date N/A was this provided?

  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3